{
  "DOI": "10.1186/s40246-023-00538-9",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-023-00538-9",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eBackground\u003c/jats:title\u003e\n                \u003cjats:p\u003eEndometriosis is a common, chronic disease among fertile-aged women. Disease course may be highly invasive, requiring extensive surgery. The etiology of endometriosis remains elusive, though a high level of heritability is well established. Several low-penetrance predisposing loci have been identified, but high-risk susceptibility remains undetermined. Endometriosis is known to increase the risk of epithelial ovarian cancers, especially of endometrioid and clear cell types. Here, we have analyzed a Finnish family where four women have been diagnosed with surgically verified, severely symptomatic endometriosis and two of the patients also with high-grade serous carcinoma.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eResults\u003c/jats:title\u003e\n                \u003cjats:p\u003eWhole-exome sequencing revealed three rare candidate predisposing variants segregating with endometriosis. The variants were c.1238C\u0026gt;T, p.(Pro413Leu) in \u003cjats:italic\u003eFGFR4\u003c/jats:italic\u003e, c.5065C\u0026gt;T, p.(Arg1689Trp) in \u003cjats:italic\u003eNALCN\u003c/jats:italic\u003e, and c.2086G\u0026gt;A, p.(Val696Met) in \u003cjats:italic\u003eNAV2\u003c/jats:italic\u003e. The only variant predicted deleterious by in silico tools was the one in \u003cjats:italic\u003eFGFR4\u003c/jats:italic\u003e. Further screening of the variants in 92 Finnish endometriosis and in 19 endometriosis–ovarian cancer patients did not reveal additional carriers. Histopathology, positive p53 immunostaining, and genetic analysis supported the high-grade serous subtype of the two tumors in the family.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eConclusions\u003c/jats:title\u003e\n                \u003cjats:p\u003eHere, we provide \u003cjats:italic\u003eFGFR4\u003c/jats:italic\u003e, \u003cjats:italic\u003eNALCN\u003c/jats:italic\u003e, and \u003cjats:italic\u003eNAV2\u003c/jats:italic\u003e as novel high-risk candidate genes for familial endometriosis. Our results also support the association of endometriosis with high-grade serous carcinoma. Further studies are required to validate the findings and to reveal the exact pathogenesis mechanisms of endometriosis. Elucidating the genetic background of endometriosis defines the etiology of the disease and provides opportunities for expedited diagnostics and personalized treatments.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e",
  "alternative-id": [
    "538"
  ],
  "article-number": "88",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "28 June 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "25 September 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "3 October 2023"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "This study has been approved by the ethics committees of Oulu University Hospital (Oulu, Finland; 94/2020), Kainuu Central Hospital (Kajaani, Finland; 4023/13 01 00/21), and Helsinki University Hospital (Helsinki, Finland; 88/13/03/03/2015). Tissue samples have been collected with an informed consent signed by the patient or with an ethics committee statement (deceased individuals). Biobank samples have been obtained with a permission from Biobank Borealis, Oulu, Finland (BB_2019_3006)."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Written informed consent was obtained from the patients, including information on publication and genetic analyses."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "The authors declare that they have no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Nousiainen",
      "given": "Susanna",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Kuismin",
      "given": "Outi",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Reinikka",
      "given": "Siiri",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Manninen",
      "given": "Roosa",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Khamaiseh",
      "given": "Sara",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kuivalainen",
      "given": "Mari",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Terho",
      "given": "Anna",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Koivurova",
      "given": "Sari",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Niinimäki",
      "given": "Maarit",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Salokas",
      "given": "Kari",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Varjosalo",
      "given": "Markku",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ahtikoski",
      "given": "Anne",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bützow",
      "given": "Ralf",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lindgren",
      "given": "Outi",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Uimari",
      "given": "Outi",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Vahteristo",
      "given": "Pia",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2023,
        10,
        3
      ]
    ],
    "date-time": "2023-10-03T10:03:16Z",
    "timestamp": 1696327396000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        11,
        21
      ]
    ],
    "date-time": "2023-11-21T18:42:22Z",
    "timestamp": 1700592142000
  },
  "funder": [
    {
      "name": "University of Helsinki Doctoral Programme in Biomedicine"
    },
    {
      "DOI": "10.13039/100008723",
      "award": [
        "10/2019"
      ],
      "doi-asserted-by": "crossref",
      "name": "Finnish Medical Foundation"
    },
    {
      "DOI": "10.13039/501100002341",
      "award": [
        "307773"
      ],
      "doi-asserted-by": "publisher",
      "name": "Academy of Finland"
    },
    {
      "DOI": "10.13039/501100006306",
      "doi-asserted-by": "crossref",
      "name": "Sigrid Jusélius Foundation"
    },
    {
      "DOI": "10.13039/100007797",
      "doi-asserted-by": "crossref",
      "name": "University of Helsinki"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2023,
        11,
        22
      ]
    ],
    "date-time": "2023-11-22T01:07:35Z",
    "timestamp": 1700615255320
  },
  "is-referenced-by-count": 0,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2023,
        10,
        3
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-online": {
      "date-parts": [
        [
          2023,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            10,
            3
          ]
        ],
        "date-time": "2023-10-03T00:00:00Z",
        "timestamp": 1696291200000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            10,
            3
          ]
        ],
        "date-time": "2023-10-03T00:00:00Z",
        "timestamp": 1696291200000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-023-00538-9.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-023-00538-9/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-023-00538-9.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2023,
        10,
        3
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2023,
        10,
        3
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1056/NEJMcp1000274",
      "author": "LC Giudice",
      "doi-asserted-by": "crossref",
      "first-page": "2389",
      "journal-title": "N Engl J Med",
      "key": "538_CR1",
      "unstructured": "Giudice LC. Endometriosis. N Engl J Med. 2010;362:2389–98.",
      "volume": "362",
      "year": "2010"
    },
    {
      "DOI": "10.1093/humrep/dex354",
      "author": "P Vigano",
      "doi-asserted-by": "crossref",
      "first-page": "347",
      "journal-title": "Hum Reprod",
      "key": "538_CR2",
      "unstructured": "Vigano P, Candiani M, Monno A, Giacomini E, Vercellini P, Somigliana E. Time to redefine endometriosis including its pro-fibrotic nature. Hum Reprod. 2018;33:347–52.",
      "volume": "33",
      "year": "2018"
    },
    {
      "DOI": "10.1056/NEJMra1810764",
      "author": "KT Zondervan",
      "doi-asserted-by": "crossref",
      "first-page": "1244",
      "journal-title": "N Engl J Med",
      "key": "538_CR3",
      "unstructured": "Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382:1244–56.",
      "volume": "382",
      "year": "2020"
    },
    {
      "DOI": "10.1038/nrendo.2013.255",
      "author": "P Vercellini",
      "doi-asserted-by": "crossref",
      "first-page": "261",
      "journal-title": "Nat Rev Endocrinol",
      "key": "538_CR4",
      "unstructured": "Vercellini P, Viganò P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10:261–75.",
      "volume": "10",
      "year": "2014"
    },
    {
      "DOI": "10.3390/jcm12030994",
      "author": "L Imperiale",
      "doi-asserted-by": "crossref",
      "first-page": "994",
      "journal-title": "J Clin Med.",
      "key": "538_CR5",
      "unstructured": "Imperiale L, Nisolle M, Noël J-C, Fastrez M. Three types of endometriosis: pathogenesis, diagnosis and treatment. State of the art. J Clin Med. 2023;12:994.",
      "volume": "12",
      "year": "2023"
    },
    {
      "DOI": "10.1016/j.fertnstert.2015.06.035",
      "author": "R Saha",
      "doi-asserted-by": "crossref",
      "first-page": "947",
      "journal-title": "Fertil Steril",
      "key": "538_CR6",
      "unstructured": "Saha R, Pettersson HJ, Svedberg P, Olovsson M, Bergqvist A, Marions L, et al. Heritability of endometriosis. Fertil Steril. 2015;104:947–52.",
      "volume": "104",
      "year": "2015"
    },
    {
      "DOI": "10.1038/ng.612",
      "author": "S Uno",
      "doi-asserted-by": "crossref",
      "first-page": "707",
      "journal-title": "Nat Genet",
      "key": "538_CR7",
      "unstructured": "Uno S, Zembutsu H, Hirasawa A, Takahashi A, Kubo M, Akahane T, et al. A genome-wide association study identifies genetic variants in the CDKN2BAS locus associated with endometriosis in Japanese. Nat Genet. 2010;42:707–10.",
      "volume": "42",
      "year": "2010"
    },
    {
      "DOI": "10.1038/ng.731",
      "author": "JN Painter",
      "doi-asserted-by": "crossref",
      "first-page": "51",
      "journal-title": "Nat Genet.",
      "key": "538_CR8",
      "unstructured": "Painter JN, Anderson CA, Nyholt DR, Macgregor S, Lin J, Lee SH, et al. Genome-wide association study identifies a locus at 7p15.2 associated with endometriosis. Nat Genet. 2011;43:51–4.",
      "volume": "43",
      "year": "2011"
    },
    {
      "DOI": "10.1371/journal.pone.0058257",
      "author": "HM Albertsen",
      "doi-asserted-by": "crossref",
      "journal-title": "PLoS ONE",
      "key": "538_CR9",
      "unstructured": "Albertsen HM, Chettier R, Farrington P, Ward K. Genome-wide association study link novel loci to endometriosis. PLoS ONE. 2013;8: e58257.",
      "volume": "8",
      "year": "2013"
    },
    {
      "DOI": "10.1038/ncomms12350",
      "author": "V Steinthorsdottir",
      "doi-asserted-by": "crossref",
      "first-page": "12350",
      "journal-title": "Nat Commun",
      "key": "538_CR10",
      "unstructured": "Steinthorsdottir V, Thorleifsson G, Aradottir K, Feenstra B, Sigurdsson A, Stefansdottir L, et al. Common variants upstream of KDR encoding VEGFR2 and in TTC39B associate with endometriosis. Nat Commun. 2016;7:12350.",
      "volume": "7",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.ejogrb.2017.08.037",
      "author": "M Sobalska-Kwapis",
      "doi-asserted-by": "crossref",
      "first-page": "106",
      "journal-title": "Eur J Obstet Gynecol Reprod Biol",
      "key": "538_CR11",
      "unstructured": "Sobalska-Kwapis M, Smolarz B, Słomka M, Szaflik T, Kępka E, Kulig B, et al. New variants near RHOJ and C2, HLA-DRA region and susceptibility to endometriosis in the Polish population—the genome-wide association study. Eur J Obstet Gynecol Reprod Biol. 2017;217:106–12.",
      "volume": "217",
      "year": "2017"
    },
    {
      "DOI": "10.1038/s41588-023-01323-z",
      "author": "N Rahmioglu",
      "doi-asserted-by": "crossref",
      "first-page": "423",
      "journal-title": "Nat Genet",
      "key": "538_CR12",
      "unstructured": "Rahmioglu N, Mortlock S, Ghiasi M, Møller PL, Stefansdottir L, Galarneau G, et al. The genetic basis of endometriosis and comorbidity with other pain and inflammatory conditions. Nat Genet. 2023;55:423–36.",
      "volume": "55",
      "year": "2023"
    },
    {
      "DOI": "10.1093/hmg/dds491",
      "author": "SH Lee",
      "doi-asserted-by": "crossref",
      "first-page": "832",
      "journal-title": "Hum Mol Genet.",
      "key": "538_CR13",
      "unstructured": "Lee SH, Harold D, Nyholt DR, ANZGene Consortium, International Endogene Consortium, the Genetic and Environmental Risk for Alzheimer’s disease (GERAD1) Consortium, et al. Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer’s disease, multiple sclerosis and endometriosis. Hum Mol Genet. 2013;22:832–41.",
      "volume": "22",
      "year": "2013"
    },
    {
      "DOI": "10.1086/432960",
      "author": "SA Treloar",
      "doi-asserted-by": "crossref",
      "first-page": "365",
      "journal-title": "Am J Hum Genet",
      "key": "538_CR14",
      "unstructured": "Treloar SA, Wicks J, Nyholt DR, Montgomery GW, Bahlo M, Smith V, et al. Genomewide linkage study in 1,176 affected sister pair families identifies a significant susceptibility locus for endometriosis on chromosome 10q26. Am J Hum Genet. 2005;77:365–76.",
      "volume": "77",
      "year": "2005"
    },
    {
      "DOI": "10.1093/humrep/del446",
      "author": "KT Zondervan",
      "doi-asserted-by": "crossref",
      "first-page": "717",
      "journal-title": "Hum Reprod",
      "key": "538_CR15",
      "unstructured": "Zondervan KT, Treloar SA, Lin J, Weeks DE, Nyholt DR, Mangion J, et al. Significant evidence of one or more susceptibility loci for endometriosis with near-Mendelian inheritance on chromosome 7p13–15. Hum Reprod. 2007;22:717–28.",
      "volume": "22",
      "year": "2007"
    },
    {
      "DOI": "10.1126/scitranslmed.abd6469",
      "author": "TT Tapmeier",
      "doi-asserted-by": "crossref",
      "first-page": "eabd6469",
      "journal-title": "Sci Transl Med.",
      "key": "538_CR16",
      "unstructured": "Tapmeier TT, Rahmioglu N, Lin J, De Leo B, Obendorf M, Raveendran M, et al. Neuropeptide S receptor 1 is a nonhormonal treatment target in endometriosis. Sci Transl Med. 2021;13:eabd6469.",
      "volume": "13",
      "year": "2021"
    },
    {
      "DOI": "10.1159/000360290",
      "author": "L Buggio",
      "doi-asserted-by": "crossref",
      "first-page": "201",
      "journal-title": "Gynecol Obstet Invest",
      "key": "538_CR17",
      "unstructured": "Buggio L, Pagliardini L, Gentilini D, Braud LD, Viganò P, Vercellini P. A Rare familial case of endometriosis with very severe gynecological and obstetric complications: novel genetic variants at a glance. Gynecol Obstet Invest. 2014;77:201–4.",
      "volume": "77",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.ejogrb.2017.11.025",
      "author": "B Isidor",
      "doi-asserted-by": "crossref",
      "first-page": "190",
      "journal-title": "Eur J Obstet Gynecol Reprod Biol",
      "key": "538_CR18",
      "unstructured": "Isidor B, Latypova X, Ploteau S. Familial deep endometriosis: A rare monogenic disease? Eur J Obstet Gynecol Reprod Biol. 2018;221:190–3.",
      "volume": "221",
      "year": "2018"
    },
    {
      "DOI": "10.3892/mmr.2017.7337",
      "author": "M Matalliotakis",
      "doi-asserted-by": "crossref",
      "first-page": "6077",
      "journal-title": "Mol Med Rep",
      "key": "538_CR19",
      "unstructured": "Matalliotakis M, Zervou MI, Matalliotaki C, Arici A, Spandidos DA, Matalliotakis I, et al. Genetic association study in a three-generation family with seven members with endometriosis. Mol Med Rep. 2017;16:6077–80.",
      "volume": "16",
      "year": "2017"
    },
    {
      "DOI": "10.1038/bjc.2014.29",
      "author": "HS Kim",
      "doi-asserted-by": "crossref",
      "first-page": "1878",
      "journal-title": "Br J Cancer",
      "key": "538_CR20",
      "unstructured": "Kim HS, Kim TH, Chung HH, Song YS. Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis. Br J Cancer. 2014;110:1878–90.",
      "volume": "110",
      "year": "2014"
    },
    {
      "DOI": "10.1097/AOG.0000000000002624",
      "author": "L Saavalainen",
      "doi-asserted-by": "crossref",
      "first-page": "1095",
      "journal-title": "Obstet Gynecol",
      "key": "538_CR21",
      "unstructured": "Saavalainen L, Lassus H, But A, Tiitinen A, Härkki P, Gissler M, et al. Risk of gynecologic cancer according to the type of endometriosis. Obstet Gynecol. 2018;131:1095–102.",
      "volume": "131",
      "year": "2018"
    },
    {
      "author": "S Mortlock",
      "journal-title": "Cell Rep Med",
      "key": "538_CR22",
      "unstructured": "Mortlock S, Corona RI, Kho PF, Pharoah P, Seo J-H, Freedman ML, et al. A multi-level investigation of the genetic relationship between endometriosis and ovarian cancer histotypes. Cell Rep Med. 2022;3:100542.",
      "volume": "3",
      "year": "2022"
    },
    {
      "DOI": "10.1093/bioinformatics/btu170",
      "author": "AM Bolger",
      "doi-asserted-by": "crossref",
      "first-page": "2114",
      "journal-title": "Bioinformatics",
      "key": "538_CR23",
      "unstructured": "Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114–20.",
      "volume": "30",
      "year": "2014"
    },
    {
      "DOI": "10.1101/gr.107524.110",
      "author": "A McKenna",
      "doi-asserted-by": "crossref",
      "first-page": "1297",
      "journal-title": "Genome Res",
      "key": "538_CR24",
      "unstructured": "McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297–303.",
      "volume": "20",
      "year": "2010"
    },
    {
      "DOI": "10.1038/s41596-018-0052-3",
      "author": "R Katainen",
      "doi-asserted-by": "crossref",
      "first-page": "2580",
      "journal-title": "Nat Protoc",
      "key": "538_CR25",
      "unstructured": "Katainen R, Donner I, Cajuso T, Kaasinen E, Palin K, Mäkinen V, et al. Discovery of potential causative mutations in human coding and noncoding genome with the interactive software BasePlayer. Nat Protoc. 2018;13:2580–600.",
      "volume": "13",
      "year": "2018"
    },
    {
      "DOI": "10.1093/nar/gkz836",
      "author": "S Fairley",
      "doi-asserted-by": "crossref",
      "first-page": "D941",
      "journal-title": "Nucleic Acids Res",
      "key": "538_CR26",
      "unstructured": "Fairley S, Lowy-Gallego E, Perry E, Flicek P. The International Genome Sample Resource (IGSR) collection of open human genomic variation resources. Nucleic Acids Res. 2020;48:D941–7.",
      "volume": "48",
      "year": "2020"
    },
    {
      "DOI": "10.1038/nature10166",
      "author": "The Cancer Genome Atlas Research Network",
      "doi-asserted-by": "crossref",
      "first-page": "609",
      "journal-title": "Nature",
      "key": "538_CR27",
      "unstructured": "The Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474:609–15.",
      "volume": "474",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.ajhg.2017.09.001",
      "author": "M Quinodoz",
      "doi-asserted-by": "crossref",
      "first-page": "623",
      "journal-title": "Am J Hum Genet",
      "key": "538_CR28",
      "unstructured": "Quinodoz M, Royer-Bertrand B, Cisarova K, Di Gioia SA, Superti-Furga A, Rivolta C. DOMINO: using machine learning to predict genes associated with dominant disorders. Am J Hum Genet. 2017;101:623–9.",
      "volume": "101",
      "year": "2017"
    },
    {
      "DOI": "10.1186/s13073-021-00835-9",
      "author": "P Rentzsch",
      "doi-asserted-by": "crossref",
      "first-page": "31",
      "journal-title": "Genome Med",
      "key": "538_CR29",
      "unstructured": "Rentzsch P, Schubach M, Shendure J, Kircher M. CADD-Splice—improving genome-wide variant effect prediction using deep learning-derived splice scores. Genome Med. 2021;13:31.",
      "volume": "13",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.ajhg.2016.08.016",
      "author": "NM Ioannidis",
      "doi-asserted-by": "crossref",
      "first-page": "877",
      "journal-title": "Am J Hum Genet",
      "key": "538_CR30",
      "unstructured": "Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, et al. REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am J Hum Genet. 2016;99:877–85.",
      "volume": "99",
      "year": "2016"
    },
    {
      "author": "RA Soslow",
      "edition": "5",
      "first-page": "45",
      "key": "538_CR31",
      "unstructured": "Soslow RA, Brenton JD, Davidson B, et al. High-grade serous carcinoma of the ovary. In: Cheung AN, Ellenson LH, Gilks CB, Kim K-R, Kong CS, Lax SF, Longacre TA, Malpica A, McCluggage WG, Oliva E, Rabban JT, Soslow RA, editors. WHO classification of tumours: female genital tumours. 5th ed. Lyon: IARC Publications; 2020. p. 45–7.",
      "volume-title": "WHO classification of tumours: female genital tumours",
      "year": "2020"
    },
    {
      "DOI": "10.1093/hmg/ddl060",
      "author": "L Peltonen",
      "doi-asserted-by": "crossref",
      "first-page": "R67",
      "journal-title": "Hum Mol Genet",
      "key": "538_CR32",
      "unstructured": "Peltonen L, Perola M, Naukkarinen J, Palotie A. Lessons from studying monogenic disease for common disease. Hum Mol Genet. 2006;15:R67-74.",
      "volume": "15",
      "year": "2006"
    },
    {
      "DOI": "10.1242/dmm.049490",
      "author": "J Uusimaa",
      "doi-asserted-by": "crossref",
      "first-page": "dmm049490",
      "journal-title": "Dis Model Mech.",
      "key": "538_CR33",
      "unstructured": "Uusimaa J, Kettunen J, Varilo T, Järvelä I, Kallijärvi J, Kääriäinen H, et al. The Finnish genetic heritage in 2022—from diagnosis to translational research. Dis Model Mech. 2022;15:dmm049490.",
      "volume": "15",
      "year": "2022"
    },
    {
      "DOI": "10.3389/fcell.2020.00095",
      "author": "Y Liu",
      "doi-asserted-by": "crossref",
      "first-page": "95",
      "journal-title": "Front Cell Dev Biol",
      "key": "538_CR34",
      "unstructured": "Liu Y, Cao M, Cai Y, Li X, Zhao C, Cui R. Dissecting the role of the FGF19-FGFR4 signaling pathway in cancer development and progression. Front Cell Dev Biol. 2020;8:95.",
      "volume": "8",
      "year": "2020"
    },
    {
      "DOI": "10.1093/nar/gky1015",
      "author": "JG Tate",
      "doi-asserted-by": "crossref",
      "first-page": "D941",
      "journal-title": "Nucleic Acids Res",
      "key": "538_CR35",
      "unstructured": "Tate JG, Bamford S, Jubb HC, Sondka Z, Beare DM, Bindal N, et al. COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res. 2019;47:D941–7.",
      "volume": "47",
      "year": "2019"
    },
    {
      "key": "538_CR36",
      "unstructured": "Cosmic. Wellcome Sanger Institute, Cambridgeshire. 2023. FGFR4 Hallmarks of Cancer https://cancer.sanger.ac.uk/cosmic/census-page/FGFR4. Accessed 15 June 2023."
    },
    {
      "DOI": "10.1016/j.pharmthera.2020.107590",
      "author": "KM Levine",
      "doi-asserted-by": "crossref",
      "journal-title": "Pharmacol Ther",
      "key": "538_CR37",
      "unstructured": "Levine KM, Ding K, Chen L, Oesterreich S. FGFR4: a promising therapeutic target for breast cancer and other solid tumors. Pharmacol Ther. 2020;214: 107590.",
      "volume": "214",
      "year": "2020"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-12-2736",
      "author": "TM Zaid",
      "doi-asserted-by": "crossref",
      "first-page": "809",
      "journal-title": "Clin Cancer Res",
      "key": "538_CR38",
      "unstructured": "Zaid TM, Yeung T-L, Thompson MS, Leung CS, Harding T, Co N-N, et al. Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancer. Clin Cancer Res. 2013;19:809–20.",
      "volume": "19",
      "year": "2013"
    },
    {
      "DOI": "10.1007/s00432-019-02986-0",
      "author": "S Heublein",
      "doi-asserted-by": "crossref",
      "first-page": "2251",
      "journal-title": "J Cancer Res Clin Oncol",
      "key": "538_CR39",
      "unstructured": "Heublein S, Anglesio MS, Marmé F, Kommoss S. Fibroblast growth factor receptor 4 (FGFR4) as detected by immunohistochemistry is associated with postoperative residual disease in ovarian cancer. J Cancer Res Clin Oncol. 2019;145:2251–9.",
      "volume": "145",
      "year": "2019"
    },
    {
      "DOI": "10.3389/fncel.2014.00132",
      "author": "M Cochet-Bissuel",
      "doi-asserted-by": "crossref",
      "first-page": "132",
      "journal-title": "Front Cell Neurosci",
      "key": "538_CR40",
      "unstructured": "Cochet-Bissuel M, Lory P, Monteil A. The sodium leak channel, NALCN, in health and disease. Front Cell Neurosci. 2014;8:132.",
      "volume": "8",
      "year": "2014"
    },
    {
      "key": "538_CR41",
      "unstructured": "Online Mendelian Inheritance in Man, OMIM®. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, Baltimore. 2023. https://www.omim.org/. Accessed 16 May 2023."
    },
    {
      "DOI": "10.1038/s41588-022-01182-0",
      "author": "EP Rahrmann",
      "doi-asserted-by": "crossref",
      "first-page": "1827",
      "journal-title": "Nat Genet",
      "key": "538_CR42",
      "unstructured": "Rahrmann EP, Shorthouse D, Jassim A, Hu LP, Ortiz M, Mahler-Araujo B, et al. The NALCN channel regulates metastasis and nonmalignant cell dissemination. Nat Genet. 2022;54:1827–38.",
      "volume": "54",
      "year": "2022"
    },
    {
      "DOI": "10.1093/molehr/gav038",
      "author": "EL Reinl",
      "doi-asserted-by": "crossref",
      "first-page": "816",
      "journal-title": "Mol Hum Reprod",
      "key": "538_CR43",
      "unstructured": "Reinl EL, Cabeza R, Gregory IA, Cahill AG, England SK. Sodium leak channel, non-selective contributes to the leak current in human myometrial smooth muscle cells from pregnant women. Mol Hum Reprod. 2015;21:816–24.",
      "volume": "21",
      "year": "2015"
    },
    {
      "DOI": "10.1159/000491805",
      "author": "EL Reinl",
      "doi-asserted-by": "crossref",
      "first-page": "503",
      "journal-title": "Cell Physiol Biochem",
      "key": "538_CR44",
      "unstructured": "Reinl EL, Zhao P, Wu W, Ma X, Amazu C, Bok R, et al. Na+-leak channel, non-selective (NALCN) regulates myometrial excitability and facilitates successful parturition. Cell Physiol Biochem. 2018;48:503–15.",
      "volume": "48",
      "year": "2018"
    },
    {
      "DOI": "10.1152/ajpendo.00320.2019",
      "author": "C Amazu",
      "doi-asserted-by": "crossref",
      "first-page": "E441",
      "journal-title": "Am J Physiol Endocrinol Metab",
      "key": "538_CR45",
      "unstructured": "Amazu C, Ma X, Henkes C, Ferreira JJ, Santi CM, England SK. Progesterone and estrogen regulate NALCN expression in human myometrial smooth muscle cells. Am J Physiol Endocrinol Metab. 2020;318:E441–52.",
      "volume": "318",
      "year": "2020"
    },
    {
      "DOI": "10.4161/cam.3.4.9451",
      "author": "EG Stringham",
      "doi-asserted-by": "crossref",
      "first-page": "342",
      "journal-title": "Cell Adh Migr",
      "key": "538_CR46",
      "unstructured": "Stringham EG, Schmidt KL. Navigating the cell. Cell Adh Migr. 2009;3:342–6.",
      "volume": "3",
      "year": "2009"
    },
    {
      "DOI": "10.1242/dev.016816",
      "author": "KL Schmidt",
      "doi-asserted-by": "crossref",
      "first-page": "563",
      "journal-title": "Development",
      "key": "538_CR47",
      "unstructured": "Schmidt KL, Marcus-Gueret N, Adeleye A, Webber J, Baillie D, Stringham EG. The cell migration molecule UNC-53/NAV2 is linked to the ARP2/3 complex by ABI-1. Development. 2009;136:563–74.",
      "volume": "136",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.ygyno.2012.11.021",
      "author": "B Davidson",
      "doi-asserted-by": "crossref",
      "first-page": "349",
      "journal-title": "Gynecol Oncol",
      "key": "538_CR48",
      "unstructured": "Davidson B, Abeler VM, Hellesylt E, Holth A, Shih I-M, Skeie-Jensen T, et al. Gene expression signatures differentiate uterine endometrial stromal sarcoma from leiomyosarcoma. Gynecol Oncol. 2013;128:349–55.",
      "volume": "128",
      "year": "2013"
    },
    {
      "DOI": "10.1007/s00428-017-2172-5",
      "author": "B Davidson",
      "doi-asserted-by": "crossref",
      "first-page": "355",
      "journal-title": "Virchows Arch",
      "key": "538_CR49",
      "unstructured": "Davidson B, Hellesylt E, Holth A, Danielsen HE, Skeie-Jensen T, Katz B. Neuron navigator-2 and cyclin D2 are new candidate prognostic markers in uterine sarcoma. Virchows Arch. 2017;471:355–62.",
      "volume": "471",
      "year": "2017"
    },
    {
      "DOI": "10.3389/frph.2021.750018",
      "author": "O Uimari",
      "doi-asserted-by": "crossref",
      "journal-title": "Front Reprod Health",
      "key": "538_CR50",
      "unstructured": "Uimari O, Nazri H, Tapmeier T. Endometriosis and uterine fibroids (Leiomyomata): comorbidity, risks and implications. Front Reprod Health. 2021;3: 750018.",
      "volume": "3",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s41467-019-12536-4",
      "author": "CS Gallagher",
      "doi-asserted-by": "crossref",
      "first-page": "4857",
      "journal-title": "Nat Commun",
      "key": "538_CR51",
      "unstructured": "Gallagher CS, Mäkinen N, Harris HR, Rahmioglu N, Uimari O, Cook JP, et al. Genome-wide association and epidemiological analyses reveal common genetic origins between uterine leiomyomata and endometriosis. Nat Commun. 2019;10:4857.",
      "volume": "10",
      "year": "2019"
    },
    {
      "DOI": "10.1093/annonc/mdz062",
      "author": "N Colombo",
      "doi-asserted-by": "crossref",
      "first-page": "672",
      "journal-title": "Ann Oncol",
      "key": "538_CR52",
      "unstructured": "Colombo N, Sessa C, du Bois A, Ledermann J, McCluggage WG, McNeish I, et al. ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. Ann Oncol. 2019;30:672–705.",
      "volume": "30",
      "year": "2019"
    },
    {
      "DOI": "10.1210/en.2018-00794",
      "author": "SE Bulun",
      "doi-asserted-by": "crossref",
      "first-page": "626",
      "journal-title": "Endocrinology",
      "key": "538_CR53",
      "unstructured": "Bulun SE, Wan Y, Matei D. Epithelial mutations in endometriosis: link to ovarian cancer. Endocrinology. 2019;160:626–38.",
      "volume": "160",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.celrep.2018.07.037",
      "author": "K Suda",
      "doi-asserted-by": "crossref",
      "first-page": "1777",
      "journal-title": "Cell Rep",
      "key": "538_CR54",
      "unstructured": "Suda K, Nakaoka H, Yoshihara K, Ishiguro T, Tamura R, Mori Y, et al. Clonal expansion and diversification of cancer-associated mutations in endometriosis and normal endometrium. Cell Rep. 2018;24:1777–89.",
      "volume": "24",
      "year": "2018"
    },
    {
      "DOI": "10.1056/NEJMoa1614814",
      "author": "MS Anglesio",
      "doi-asserted-by": "crossref",
      "first-page": "1835",
      "journal-title": "N Engl J Med",
      "key": "538_CR55",
      "unstructured": "Anglesio MS, Papadopoulos N, Ayhan A, Nazeran TM, Noë M, Horlings HM, et al. Cancer-associated mutations in endometriosis without cancer. N Engl J Med. 2017;376:1835–48.",
      "volume": "376",
      "year": "2017"
    },
    {
      "DOI": "10.1186/s13048-021-00865-2",
      "author": "KA So",
      "doi-asserted-by": "crossref",
      "first-page": "110",
      "journal-title": "J Ovarian Res",
      "key": "538_CR56",
      "unstructured": "So KA, Hong SR, Kim NR, Yang EJ, Shim S-H, Lee SJ, et al. Association between atypical endometriosis and ovarian malignancies in the real world. J Ovarian Res. 2021;14:110.",
      "volume": "14",
      "year": "2021"
    },
    {
      "DOI": "10.1097/PGP.0000000000000952",
      "author": "C Wepy",
      "doi-asserted-by": "publisher",
      "journal-title": "Int J Gynecol Pathol",
      "key": "538_CR57",
      "unstructured": "Wepy C, Nucci MR, Parra-Herran C. Atypical endometriosis: comprehensive characterization of clinicopathologic, immunohistochemical, and molecular features. Int J Gynecol Pathol. 2023. https://doi.org/10.1097/PGP.0000000000000952.",
      "year": "2023"
    }
  ],
  "reference-count": 57,
  "references-count": 57,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-023-00538-9"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Whole-exome sequencing reveals candidate high-risk susceptibility genes for endometriosis"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "17"
}